挺进美女教师的蜜桃肥臀视频-同性恋一级片-同性情a三级a三级a三级-同性做爰猛烈全过程-91丨porny丨国产麻豆-91丨porny丨国产入口

大連百奧泰科技 Biteomics
大連百奧泰科技有限公司是由海外華人科學家創(chuàng)立的生物高科技公司，位于大連市高新技術產(chǎn)業(yè)園區(qū)。目前，公司業(yè)務涉及到代理銷售國際著名品牌的各種高效增加石油和天然氣產(chǎn)量的生物工程酶、含氟氨基酸的生產(chǎn)、多肽合成和國際貿(mào)易、新藥研發(fā)、國際咨詢與高端會議組織等。 正在主攻糖尿病、抗艾滋病藥物及其他抗感染類藥物的開發(fā)與研制。


百奧泰公司經(jīng)過八年堅持不懈的奮斗，現(xiàn)已成為國家外國專家局附屬的唯一一家“國外人才資源總庫大連生物與醫(yī)藥人才分庫”的內資企業(yè)，是國內一流、國際領先的專業(yè)高端會議組織公司。同時，公司還在能源和環(huán)保產(chǎn)業(yè)前沿生物技術產(chǎn)品的開發(fā)和應用方面獨樹一幟，業(yè)績斐然。公司現(xiàn)有員工近400人，均為本科以上學歷，其中博士生占5%，研究生占50%以上。公司在全國各地擁有5個分支機構及一所生命科學院，兩個子公司，一個合資公司。2010年4月，在大連長興島國家級經(jīng)濟技術開發(fā)區(qū)開工建設百奧泰酶工程中心及產(chǎn)業(yè)化基地，占地6.6萬平。

公司的優(yōu)勢在于擁有雄厚的技術實力和一流的研發(fā)隊伍。公司所有員工均是本科以上學歷，并且匯聚了眾多博士、碩士等高級專業(yè)人才。其中，博士生占10%，研究生占30%。同時，公司擁有海外杰出的創(chuàng)始人和技術實力強大的專家顧問團，在對藥物進行篩選立項、新藥研發(fā)、仿制藥委托研究、申報轉讓、以及產(chǎn)品工業(yè)化生產(chǎn)等領域經(jīng)驗豐富。通過多年運作，公司與美國上市公司DEVERSA，美國 CalenTrack，以色列理工學院、美國Clonetech 公司、美國新英格蘭實驗室、美國哈佛、耶魯、斯坦福、塔夫茲等國內外知名科研機構、醫(yī)院及醫(yī)藥企業(yè)進行了長期合作關系。

Dalian Biteomics, Inc. lies in High Tech Zone, Dalian China is a high-tech biology company established by overseas Chinese scientists. Currently, the business of company involves distribution of international brands of enzymes which can increase the output of petrol and natural gas, producing of fluorine amino acid, and peptide synthesis, also involves international trade, drug discovery, consulting and organizing of high-end conferences etc. We are working on R&D of anti-infective medicines against diabetes, AIDS and other infective diseases.

With 8 years endeavor, Biteomics now is the only domestic company as Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical Experts Subdivision. It has become accepted as the professional high-end conference organizer leading the nation and the world. Meanwhile, the company also has outstanding performance in the developing and applying of energy and cutting-edge biotechnological products for environmental protection. The company currently employs nearly 400 people with undergraduate education among which 5% are with doctoral degree, and 50% are with master degree. The company has five branch organizations, one life sciences institute, two subsidiaries and a joint venture nation wide.

The company’s advantage lies in the strong technical strength and first class research and development team. In addition, all the employees of our company hold the degree of bachelor or above. Among them, 10% are doctors and 30% are postgraduates. Meanwhile, we have frontier technologies and a strong group of consultants with great experiences in drug screening and projecting, drug discovery, generic drugs commission and research, transfer reporting, and industrial production. During years' operation, our company has established broad partnership with universities, research institutions and corporations, such as DEVERSA, CalenTrack, Technion-Israel Institute of Technology, Clonetech Ltd, New England Lab, Harvard University, Stanford University, and Yale University etc.